An immunohistochemical (IHC) assay was performed to examine the expression of NRF2 protein in the tumor microarray (TMA) composed of lung cancer tissue samples from patients diagnosed with LUSC or LUAD and adjacent noncancerous tissues as controls. This evidence concerns the gene NFE2L2 and lung carcinoma.